OF-1 Epigenetic Reader Domain inhibitor

Cat.No.S7681

OF-1 is a potent inhibitor of BRPF1B and BRPF2 bromodomain with Kd of 100 nM and 500 nM, respectively.
OF-1 Epigenetic Reader Domain inhibitor Chemical Structure

Chemical Structure

Molecular Weight: 440.31

Quality Control

Batch: S768101 DMSO]76 mg/mL]false]Water]Insoluble]false]Ethanol]Insoluble]false Purity: 99.19%
99.19

Chemical Information, Storage & Stability

Molecular Weight 440.31 Formula

C17H18BrN3O4S

Storage (From the date of receipt)
CAS No. 919973-83-4 Download SDF Storage of Stock Solutions

Synonyms N/A Smiles CC1=C(C=CC(=C1)Br)S(=O)(=O)NC2=CC3=C(C=C2OC)N(C(=O)N3C)C

Solubility

In vitro
Batch:

DMSO : 76 mg/mL (172.6 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : Insoluble

Ethanol : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Targets/IC50/Ki
BRPF1B [1]
100 nM(Kd)
BRPF2 [1]
500 nM(Kd)
In vitro
As a chemical probe for BRPF bromodomains, OF-1 increases thermal stability in the cellular thermal shift assay of full length BRPF1B at 1 μM and also demonstrates accelerated FRAP recovery at 5 μM in the BRPF2 FRAP assay. In addition, this compound shows modest general cytotoxicity. [1]
References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT06406816 Not yet recruiting
Intrahepatic Cholangiocarcinoma
Yongyi Zeng|Meng Chao Hepatobiliary Hospital of Fujian Medical University
May 2024 Early Phase 1
NCT06407518 Not yet recruiting
Preoperative|Sleep Disturbance|Anxiety|Midazolam|Pain Postoperative
Sixth Affiliated Hospital Sun Yat-sen University
May 2024 Not Applicable
NCT06402110 Recruiting
Femoral Triangle Block|Adductor Canal Block|Anterior Cruciate Ligament Reconstruction
Tanta University
May 7 2024 Not Applicable

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.

Signaling Pathway Map